1. Home
  2. GNFT vs MED Comparison

GNFT vs MED Comparison

Compare GNFT & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • MED
  • Stock Information
  • Founded
  • GNFT 1999
  • MED 1980
  • Country
  • GNFT France
  • MED United States
  • Employees
  • GNFT N/A
  • MED N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • MED Packaged Foods
  • Sector
  • GNFT Health Care
  • MED Consumer Staples
  • Exchange
  • GNFT Nasdaq
  • MED Nasdaq
  • Market Cap
  • GNFT 179.7M
  • MED 187.3M
  • IPO Year
  • GNFT 2019
  • MED N/A
  • Fundamental
  • Price
  • GNFT $3.91
  • MED $15.41
  • Analyst Decision
  • GNFT Strong Buy
  • MED Hold
  • Analyst Count
  • GNFT 1
  • MED 1
  • Target Price
  • GNFT $13.00
  • MED $17.00
  • AVG Volume (30 Days)
  • GNFT 9.9K
  • MED 204.6K
  • Earning Date
  • GNFT 09-19-2024
  • MED 02-18-2025
  • Dividend Yield
  • GNFT N/A
  • MED N/A
  • EPS Growth
  • GNFT N/A
  • MED N/A
  • EPS
  • GNFT 0.47
  • MED 0.67
  • Revenue
  • GNFT $86,225,222.00
  • MED $674,475,000.00
  • Revenue This Year
  • GNFT $145.20
  • MED N/A
  • Revenue Next Year
  • GNFT N/A
  • MED N/A
  • P/E Ratio
  • GNFT $7.89
  • MED $23.25
  • Revenue Growth
  • GNFT 175.45
  • MED N/A
  • 52 Week Low
  • GNFT $3.35
  • MED $14.88
  • 52 Week High
  • GNFT $6.42
  • MED $56.52
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 54.95
  • MED 36.38
  • Support Level
  • GNFT $3.68
  • MED $15.67
  • Resistance Level
  • GNFT $3.96
  • MED $16.30
  • Average True Range (ATR)
  • GNFT 0.13
  • MED 0.55
  • MACD
  • GNFT 0.05
  • MED 0.09
  • Stochastic Oscillator
  • GNFT 79.49
  • MED 25.16

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About MED MEDIFAST INC

Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.

Share on Social Networks: